Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
Chao Zheng, Ellen Wang, Jiangshan Li, et al.
BMC Geriatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of…
Aurélie Ladang, Charlotte Beaudart, Jean‐Yves Reginster, et al.
Calcified Tissue International (2023) Vol. 112, Iss. 2, pp. 197-217
Open Access | Times Cited: 39
Correlation between sarcopenia and esophageal cancer: a narrative review
Shenglan Li, Kaiqiang Xie, Xiaoxiong Xiao, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States
Tianbo Wang, Yuxin Zhu, Xiaohan Liu, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Blood biomarkers for sarcopenia: A systematic review and meta-analysis of diagnostic test accuracy studies
Rongna Lian, Qianqian Liu, Gengchen Jiang, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102148-102148
Closed Access | Times Cited: 20
Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
Wen-He Zheng, Yibing Zhu, Yan Yao, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 19
Sex‐specific associations between skeletal muscle mass and incident diabetes: A population‐based cohort study
Dan Liu, Nan Li, Yiling Zhou, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 3, pp. 820-828
Closed Access | Times Cited: 16
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia in individuals with cancer: a cross-sectional study
Ran He, Y. Ye, Qilei Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
Pingan Ding, Honghai Guo, Chenyu Sun, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 22
Low sarcopenia index predicts intra-abdominal infection in patients with abdominal trauma
Fengchan Xi, Ran Teng, Bing Xiong, et al.
Nutrition (2025) Vol. 133, pp. 112695-112695
Closed Access
Higher Preprocedual Nutrition Intake Reduces the Loss of Relative Muscle Mass After Transcatheter Aortic Valve Implantation
Qian You, Yingyi Chen, Minggang Zhou, et al.
Topics in Clinical Nutrition (2025) Vol. 40, Iss. 2, pp. 139-149
Closed Access
Role of Serum Creatinine-to-Cystatin C Ratio in Predicting Postoperative Infectious Complications After Major Urologic Cancer Surgery
Ryo Andy Ogasawara, Shugo Yajima, Naoki Imasato, et al.
Research Square (Research Square) (2025)
Closed Access
Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients
Camille Tlemsani, Jean-Philippe Durand, Bruno Raynard, et al.
Clinical Nutrition ESPEN (2022) Vol. 51, pp. 412-418
Open Access | Times Cited: 19
Usefulness of the serum creatinine/cystatin C ratio as a blood biomarker for sarcopenia components among age groups in community‐dwelling older people: The SONIC study
Fang Wen, Kayo Godai, Mai Kabayama, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 6, pp. 529-536
Open Access | Times Cited: 4
Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients
M. Yuzefpolskaya, Bruno Bohn, Annamaria Ladanyi, et al.
The Journal of Heart and Lung Transplantation (2024) Vol. 43, Iss. 9, pp. 1395-1408
Open Access | Times Cited: 4
Mechanisms, assessment, and exercise interventions for skeletal muscle dysfunction post-chemotherapy in breast cancer: from inflammation factors to clinical practice
Zhong Pei, X Li, Jiehua Li
Frontiers in Oncology (2025) Vol. 15
Open Access
Low creatinine to cystatin C ratio is associated with lower muscle volumes and poorer gait speeds in the longitudinal Integrated Women's Health Program cohort
David S.P. Tan, Beverly Wen Xin Wong, Liang Shen, et al.
Menopause The Journal of The North American Menopause Society (2025)
Closed Access
Creatinine-cystatin C ratio as a promising prognostic biomarker in patients with UTUC after radical nephroureterectomy
Lei Zheng, Jianjun Ye, Qihao Wang, et al.
Clinical Genitourinary Cancer (2025), pp. 102352-102352
Closed Access
The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study
Xiangping Tu, Taiping Lin, Li Huang, et al.
European Geriatric Medicine (2024) Vol. 15, Iss. 2, pp. 579-588
Closed Access | Times Cited: 3
Diagnostic accuracy of a ‘sarcopenia index’ based on serum biomarkers creatinine and cystatin C in 458,702 UK Biobank participants
Thomas J. Wilkinson, Luke A Baker, Emma Watson, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 207-213
Open Access | Times Cited: 3
Low Skeletal Muscle Mass and Clinical Outcomes in Chronic Obstructive Pulmonary Disease
Yong Jun Choi, Hye Jung Park, Jae Hwa Cho, et al.
Tuberculosis & respiratory diseases (2023) Vol. 86, Iss. 4, pp. 272-283
Open Access | Times Cited: 8
Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma
Benjamin N. Schmeusser, Adil Ali, Florian J. Fintelmann, et al.
Current Urology Reports (2023) Vol. 24, Iss. 7, pp. 317-334
Open Access | Times Cited: 7
Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
Shunhui Gao, Hailun Xie, Lishuang Wei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Assessing Frailty in Gastrointestinal Cancer: Two Diseases in One?
Ishan Patel, Arthur Winer
Current Oncology Reports (2024) Vol. 26, Iss. 1, pp. 90-102
Closed Access | Times Cited: 2
Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer
Hongjuan Ji, Bona Liu, Peng Jin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Zhixiang Chen, Lei Zha, Xiao Ma, et al.
Lung (2022) Vol. 200, Iss. 5, pp. 609-617
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top